Zimmer Biomet (ZBH) executive exercises 7,004 RSUs, holds 30,991 shares

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Zimmer Biomet Holdings, Inc. Group President EMEA Wilfred Van Zuilen exercised restricted stock units on March 6, 2026, converting 7,004 RSUs into common shares. The company withheld 1,822 shares at $92.54 per share to cover tax obligations, leaving a net 5,182 shares. Following these compensation-related transactions, he directly holds 30,991 shares of common stock.

Insider Trade Summary

7,004 shares exercised/converted

Mixed 6 txns

Insider VAN ZUILEN WILFRED

Role Group Pres, EMEA

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	4,843	$0.00	--
Exercise	Restricted Stock Units	2,161	$0.00	--
Exercise	Common Stock	4,843	$0.00	--
Tax Withholding	Common Stock	1,260	$92.54	$117K
Exercise	Common Stock	2,161	$0.00	--
Tax Withholding	Common Stock	562	$92.54	$52K

Holdings After Transaction: Restricted Stock Units — 0 shares (Direct); Common Stock — 30,652 shares (Direct)

Footnotes (1)

Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Company common stock.

Form 4 Insider Transactions: What Each Field Means →

03/10/2026 - 04:09 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

VAN ZUILEN WILFRED

(Last)

(First)

(Middle)

345 E. MAIN STREET

(Street)

WARSAW

46580

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
ZIMMER BIOMET HOLDINGS, INC. [ ZBH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Group Pres, EMEA

3. Date of Earliest Transaction (Month/Day/Year)
03/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/06/2026		M		4,843	A	$0	30,652	D
Common Stock	03/06/2026		F		1,260⁽¹⁾	D	$92.54	29,392	D
Common Stock	03/06/2026		M		2,161	A	$0	31,553	D
Common Stock	03/06/2026		F		562⁽¹⁾	D	$92.54	30,991	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽²⁾	03/06/2026		M			4,843	03/06/2026	03/06/2026	Common Stock	4,843	$0	0	D
Restricted Stock Units	⁽²⁾	03/06/2026		M			2,161	03/06/2026	03/06/2026	Common Stock	2,161	$0	0	D

Explanation of Responses:

1. Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

2. Each RSU represents a contingent right to receive one share of Company common stock.

	/s/ Matthew R. St. Louis, Attorney-in-Fact for Wilfred van Zuilen (power of attorney previously filed)	03/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did ZIMMER BIOMET (ZBH) report for Wilfred Van Zuilen?

Zimmer Biomet reported that Group President EMEA Wilfred Van Zuilen exercised restricted stock units, converting 7,004 RSUs into common stock. These transactions are compensation-related rather than open-market purchases or sales, reflecting equity awards vesting into regular shares.

How many Zimmer Biomet RSUs did Wilfred Van Zuilen exercise in this Form 4?

He exercised a total of 7,004 restricted stock units into common stock on March 6, 2026. This came from 4,843 RSUs in one transaction and 2,161 RSUs in a second, each RSU representing one share of Zimmer Biomet common stock.

How many Zimmer Biomet shares were withheld for taxes in this Form 4?

Zimmer Biomet withheld 1,822 shares of common stock to satisfy tax obligations triggered by the RSU vesting. The withholding occurred through two F-code transactions of 1,260 and 562 shares, both valued at $92.54 per share for tax purposes.

What is Wilfred Van Zuilen’s Zimmer Biomet shareholding after these transactions?

After the RSU exercises and tax-withholding dispositions, Wilfred Van Zuilen directly holds 30,991 shares of Zimmer Biomet common stock. This figure reflects his updated position following all Form 4 transactions reported for March 6, 2026.

Were any open-market buys or sells reported in this Zimmer Biomet Form 4?

No open-market buys or sells were reported. All transactions were coded M and F, reflecting RSU exercises and shares withheld to pay taxes. These are routine compensation and tax events rather than discretionary market purchases or sales.